Rivaroxaban, an Oral, Direct Factor Xa Inhibitor: A New Option for Thromboprophylaxis
Author:
Publisher
SLACK, Inc.
Subject
Orthopedics and Sports Medicine,Surgery
Reference37 articles.
1. Prevention of Venous Thromboembolism
2. Prevention of Venous Thromboembolism
3. Physician compliance with guidelines for deep-vein thrombosis prevention in total hip and knee arthroplasty;Friedman RJ;Curr Med Res Opin,2008
4. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
5. Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939—an oral, direct Factor Xa inhibitor—after multiple dosing in healthy male subjects
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Rivaroxaban versus Aspirin in Prevention of Venous Thromboembolism: A Meta-Analysis of 9 Randomized Controlled Trials comprising 7,656 Patients;Thrombosis and Haemostasis;2019-07-31
2. The Efficacy and Safety of Combination of Intravenous and Topical Tranexamic Acid in Revision Hip Arthroplasty: A Randomized, Controlled Trial;The Journal of Arthroplasty;2016-11
3. Combination of Erythropoietin and Tranexamic Acid in Bilateral Simultaneous Total HIP Arthroplasty: A Randomised, Controlled Trial;HIP International;2016-04-21
4. Comparison of the effects of heparin and the direct factor Xa inhibitor, rivaroxaban, on bone microstructure and metabolism in adult rats;Connective Tissue Research;2015-08-25
5. Gastrointestinal bleeding with the new oral anticoagulants – defining the issues and the management strategies;Thrombosis and Haemostasis;2013
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3